CE
CERo Therapeutics Holdings, Inc.
CERO · OTC
$0.01 +0.00% (+$0.00)
1M -33.54%
Market Cap $473.7K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 2,354.69%
Asset turnover 0.00x
ROIC 79.91%
Debt
57 /100
Moderate Int. coverage 26.03x
Current ratio 0.05x
Net debt/EBITDA N/A
Stability
1 /100
Unstable EPS volatility 7,214.36%
Profitable years 0
Beta 0.16x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CERO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher Ehrlich
Employees
8
Headquarters
South San Francisco
Upcoming events
02 DEC
Earnings
Upcoming earnings report